Production and purification of recombinant protective antigen and protective efficacy against Bacillus anthracis

Letters in Applied Microbiology

Volumn 26, Issue 1, 1998, Pages 56-60

  Miller, J ^a   McBride, B W ^b   Manchee, R J ^a   Moore, P ^a   Baillie, L W J ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b Centre for Applied Microbiology and Research   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; BACTERIOLOGY; GEL PERMEATION CHROMATOGRAPHY; SULFUR COMPOUNDS;

'CURRENT; ALHYDROGEL; ANION EXCHANGE CHROMATOGRAPHY; B.ANTHRACIS; BACILLUS ANTHRACIS; BACILLUS SUBTILIS; CULTURE SUPERNATANT; GEL-FILTRATION CHROMATOGRAPHY; PROTECTIVE ANTIGENS; PROTECTIVE EFFICACY;

PURIFICATION;

AMMONIUM SULFATE; BACTERIAL VACCINE;

ANION EXCHANGE CHROMATOGRAPHY; ANTIGEN PRESENTATION; ANTIGEN PURIFICATION; ARTICLE; BACILLUS ANTHRACIS; GUINEA PIG; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS;

BACILLUS ANTHRACIS; BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); CAVIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0031931788     PISSN: 02668254     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-765X.1998.00274.x     Document Type: Article

References (16)

1. Baillie, L.W.J., Moore, P. and Manchee, R.J. (1995) Development of a Bacillus subtilis based system for the expression of the protective antigen of Bacillus anthracis. In Proceedings of the International Workshop on Anthrax, Salisbury Medical Bulletin, Special Supplement, 87, 133-135.
2. Belton, F.C. and Strange, R.E. (1954) Studies on a protective antigen produced in vitro from Bacillus anthracis: medium and methods of production. British Journal of Experimental Pathology 35, 144-152.
3. Broster, M.G. and Hibbs, S.E. (1990) Protective efficacy of anthrax vaccines against aerosol challenge. In Proceedings of the International Workshop on Anthrax, Salisbury Medical Bulletin, Special Supplement, 68, 91-92.
4. Escuyer, V. and Collier, R.J. (1991) Anthrax protective antigen interacts with a specific receptor on the surface of CHO-K1 cells. Infection and Immunity 59, 3381-3386.
5. Ezzell, J.W., Ivins, B.E. and Leppla, S.H. (1984) Immuno-electrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin. Infection and Immunity 45, 761-767.
6. Friedlander, A.M. (1986) Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. Journal of Biological Chemistry 261, 7123-7126.
7. Ivins, B., Fellows, P., Pitt, L. et al. (1995) Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs. Vaccine 13, 1779-1784.
8. Ivins, B.E. and Welkos, S.F. (1986) Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis. Infection and Immunity 54, 537-542.
9. Jones, M.N., Beedham, R.J., Turnbull, P.C.B., Fitzgeorge, R.B. and Manchee, R.J. (1995) Efficacy of the UK human anthrax vaccine in guinea pigs against aerosolised spores of Bacillus anthracis. In Proceedings of the International Workshop on Anthrax, Salisbury Medical Bulletin, Special Supplement, 87, 123-124.
10. Leppla, S.H. (1991) The anthrax toxin complex. In Sourcebook of Bacterial Toxins ed. Alouf, J.E. and Freer, J.H. pp. 277-302. San Diego: Academic Press.
11. Leppla, S.H. (1995) In Bacterial Toxins and Virulence Factors in Disease ed. Moss, J., Iglewski, B., Vaughan, M. and Tu, A.T. pp. 543-572. New York: Marcel Dekker.
12. Leppla, S.H., Friedlander, A.M. and Cora, E.M. (1987) Proteolytic activation of anthrax toxin bound to cellular receptors. In Bacterial Protein Toxins ed. Fehrenbach, F., Alouf, J.E., Falmagne, P. et al. pp. 111-112. Stuttgart: Gustav Fischer.
13. Novak, J.M., Stein, M.-P., Little, S.F., Leppla, S.H. and Friedlander, A.M. (1992) Functional characterization of protease-treated Bacillus anthracis protective antigen. Journal of Biological Chemistry 267, 17186-17193.
14. Singh, Y., Chaudhary, V.K. and Leppla, S.H. (1989) A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxic action in vivo. Journal of Biological Chemistry 264, 19103-19107.
15. Smith, P.K., Krohn, R.I., Hermanson, A.K. et al. (1985) Measurement of protein using bicinchoninic acid. Analytical Biochemistry 150, 76-85.
16. Stanley, J.L., Sargeant, J. and Smith, H. (1960) Purification of anthrax toxin factors I and II of the anthrax toxin produced in vivo. Journal of General Microbiology 22, 206-218.